MedTech Innovation and Mining Recovery Define Q4 2025 Earnings
Beta Bionics and NeoGenomics posted strong Q4 2025 results driven by automated insulin delivery and oncology diagnostics, respectively. Meanwhile, SSR Mining focused on operational stabilization and cost discipline following a volatile fiscal year for precious metals.